Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study
M H Jagasia, C J Langer, D H Johnson, et al.
Seminars in Oncology
|
January 14, 1998
Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study
D I Rosenthal, R J Sinard, O Okani, et al.
Gynecologic Oncology
|
November 1, 1995
Adenovirus-based p53 gene therapy in ovarian cancer
J T Santoso, D C Tang, S B Lane, et al.
Journal of Korean Medical Science
|
June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissues
J H Kim, J J Choi, S H Noh, et al.
ESMO Open
|
September 13, 2023
Genomic characterization of thymic epithelial tumors in a real-world dataset
K Kurokawa, T Shukuya, R A Greenstein, et al.
Seminars in Oncology
|
February 1, 1997
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies
D I Rosenthal, O Okani, J M Truelson, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
NCI-Navy Medical Oncology Branch cell line data base
R M Phelps, B E Johnson, D C Ihde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck
D I Rosenthal, J H Lee, R Sinard, et al.
Cancer Research
|
September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology
T Tsukui, A Hildesheim, M H Schiffman, et al.
ESMO Open
|
May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA
D P Carbone, T-E Ciuleanu, M Cobo, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study
M H Jagasia, C J Langer, D H Johnson, et al.
Seminars in Oncology
|
January 14, 1998
Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study
D I Rosenthal, R J Sinard, O Okani, et al.
Gynecologic Oncology
|
November 1, 1995
Adenovirus-based p53 gene therapy in ovarian cancer
J T Santoso, D C Tang, S B Lane, et al.
Journal of Korean Medical Science
|
June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissues
J H Kim, J J Choi, S H Noh, et al.
ESMO Open
|
September 13, 2023
Genomic characterization of thymic epithelial tumors in a real-world dataset
K Kurokawa, T Shukuya, R A Greenstein, et al.
Seminars in Oncology
|
February 1, 1997
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies
D I Rosenthal, O Okani, J M Truelson, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
NCI-Navy Medical Oncology Branch cell line data base
R M Phelps, B E Johnson, D C Ihde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck
D I Rosenthal, J H Lee, R Sinard, et al.
Cancer Research
|
September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology
T Tsukui, A Hildesheim, M H Schiffman, et al.
ESMO Open
|
May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA
D P Carbone, T-E Ciuleanu, M Cobo, et al.
Page
of 10